RedHill Biopharma Ltd. announced the voluntary resignation of Mr. Giuseppe Cipriano from the company’s Board of Directors, following his resignation from his position as Chief Operating Officer of Cosmo Pharmaceuticals NV for personal reasons, and the appointment of Mr. Alessandro Della Chà to the RedHill Board of Directors, effective as of February 1, 2021. Mr. Della Chà has served as the Chief Executive Officer of Cosmo Pharmaceuticals NV since 2014 and as a board member since 2006. In addition, Mr. Della Chà serves as a board member of Acacia Pharma Group plc. Mr. Della Chà received a degree in law from the University of Milan, Italy, and an LL.M. in European Union commercial law from the University of Leicester, United Kingdom.